Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: A prospective analysis from the Finmark Study

Archives of Internal Medicine

Volumn 158, Issue 12, 1998, Pages 1326-1332

  Njølstad, Inger ^a   Arnesen, Egil ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NORWAY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SUDDEN DEATH; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; SEX DISTRIBUTION; SMOKING; SURVIVAL RATE;

EID: 0031861976     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.12.1326     Document Type: Article

References (53)

1. Weinblatt E, Shapiro S, Frank CW, Sager RV. Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health. 1968;58:1329-1347.
2. Westlund K. Myocardial infarction in Oslo 1967-69: incidence and case fatality. J Oslo City Hospitals. 1972;22:77-108.
3. Romo M. Factors related to sudden death in acute ischaemic heart disease: a community study in Helsinki. Acta Med Scand. 1972;547(suppl):1-92.
4. Kannel WB, Thomas HE Jr. Sudden coronary death: The Framingham Study. Ann N Y Acad Sci. 1982;382:3-20.
5. Gillum RF, Folsom A, Luepker RV, et al. Sudden death and acute myocardial infarction in a metropolitan area, 1970-1980: The Minnesota Heart Survey. N Engl J Med. 1983;309:1353-1358.
6. Johansson S, Vedin A, Wilhelmsson C, Wedel H, Wilhelmsen L. Myocardial infarction among women in Göteborg, Sweden: a community study of mortality and incidence, 1968-1977. Am J Epidemiol. 1984;119:603-609.
7. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Incidence and case fatality rates of acute myocardial infarction (1975-1984): The Worcester Heart Attack Study. Am Heart J. 1988;115:761-767.
8. Kannel WB, Sorlie P, Castelli WP, McGee D. Blood pressure and survival after myocardial infarction: The Framingham Study. Am J Cardiol. 1980;45:326-330.
9. Bourke S, Conroy RM, Mulcachy R, Robinson K. Aetiological and prognostic correlates of site of myocardial infarction. Eur Heart J. 1988:9:734-739.
10. Enomoto N, Yamauchi K, Hayashi H. et al. Influence of risk factors on long-term survival following acute myocardial infarction: a follow-up study in central Japan. Clin Cardiol. 1989;12:491-499.
11. Wong ND, Cupples A, Ostfeld AM, Levy D, Kannel WB. Risk factors for longterm coronary prognosis after initial myocardial infarction: The Framingham Study. Am J Epidemiol. 1989;130:469-480.
12. Wannamethee G, Whincup PH, Shaper AG, Walker M, MacFarlane PW. Factors determining case fatality in myocardial infarction: "who dies in a heart attack?" Br Heart J. 1995;74:324-331.
13. Wilcox RG, Hampton JR. Importance of age in prehospital and hospital mortality of heart attacks. Br Heart J. 1980;44:503-507.
14. Pohjola S, Sutanen P, Romo M. Five-year survival of 728 patients after myocardial infarction: a community study. Br Heart J. 1980;43:176-183.
15. Goldberg RJ, Gore JM, Gurwitz JH, et al. The impact of age on the incidence and prognosis of initial acute myocardial infarction: The Worcester Heart Attack Study. Am Heart J. 1989;117:543-549.
16. Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL. Myocardial infarct size and mortality in diabetic patients. Br Heart J. 1985;54:466-472.
17. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: The Framingham Study. JAMA. 1988;260:3456-3460.
18. Donahue RP, Goldberg RJ, Chen Z, Gore JM, Alpert JS. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective. J Clin Epidemiol. 1993;46:245-252.
19. Johansson S, Bergstrand R, Ulvenstam G, et al. Sex differences in preinfarction characteristics and long-term survival among patients with myocardial infarction. Am J Epidemiol. 1984;119:610-623.
20. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S, and the Israeli SPRINT Investigators. In-hospital and 1-year mortality in 1,524 women after myocardial infarction: comparison with 4,315 men. Circulation. 1991;83:484-491.
21. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol. 1988;62:1-7.
22. Goldberg RJ, Gorak EJ, Yarzebski J, et al. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation. 1993;87:1947-1953.
23. Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease: an investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation. 1993;88:2548-2555.
24. Orencia A, Bailey K, Yawn BP, Kottke TE. Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death. JAMA. 1993;269:2392-2397.
25. Karlson BW, Herlitz J, Hartford M. Prognosis in myocardial infarction in relation to gender. Am Heart J. 1994;128:477-483.
26. Geltman EM, Ehsani AA, Campbell MK, Schechtman K, Roberts R, Sobel BE. The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation. 1979;60:805-814.
27. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The Cardiovascular Disease Study in Norwegian Counties: background and organization. Acta Med Scand. 1979; 634(suppl):1-70.
28. National Health Screening Service, Health Services of Finnmark, Oppland, and Sogn og Fjordane Counties, Ullevål Hospital, Central Laboratory, Oslo. The Cardiovascular Disease Study in Norwegian Counties: Results From Second Screening. Oslo, Norway: National Health Screening Service; 1988.
29. Foss OP, Lund-Larsen PG. Serum thiocyanate and smoking: interpretation of serum thiocyanate levels observed in a large health study. Scand J Clin Lab Invest. 1986;46:245-251.
30. Thelle DS, Førde OH, Arnesen E. Distribution of high-density lipoprotein choies terol according to age, sex, and ethnic origin: cardiovascular disease study in Finnmark 1977. J Epidemiol Community Health. 1982;36:243-247.
31. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
32. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: 12-year follow-up of the Finnmark Study. Circulation. 1996;93:450-456.
33. World Health Organization. International Classification of Diseases, Eighth Revision (ICD-8). Geneva, Switzerland: World Health Organization; 1967.
34. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993; 153:154-183.
35. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A, for the WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
36. Pohjola-Sintonen S, Sutanen P, Haapakoski J, Romo M. The mortality and case fatality rates in acute myocardial infarction in Finland: the results of Helsinki Coronary Register during 1970-1977. Eur Heart J. 1987;8:354-359.
37. Kvamme JI. Reformer i distriktsheisetjenesten III: Hypertension i distriktshelsetjenesten - ISM skriftserie Nr. 5. Tromsø, Norway: University of Tromsø; 1980.
38. Rakugi H, Yu H, Kamitani A, et al. Links between hypertension and myocardial infarction. Am Heart J. 1996;132:213-221.
39. James MA, Jones JV. Ventricular arrhythmia in untreated newly presenting hypertensive patients compared with matched normal population. J Hypertens. 1989; 7:409-415.
40. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echo- cardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann Intern Med. 1988;108:7-13.
41. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med. 1990;322:1561-1566.
42. Kaplinsky E. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther. 1994;8:549-556.
43. Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 1990;322: 1350-1356.
44. Kuller LH, Hulley SB, Cohen JD, Neaton J. Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis. Circulation. 1986;73:114-123.
45. Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985;1:1349-1354.
46. Jafri SM, Tilley BC, Peters R, Schultz LR, Goldstein S. Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. Am J Cardiol. 1990;65:271-276.
47. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-807.
48. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
49. Kannel WB, Cupples LA, D'Agostino RB, Stokes J 3d. Hypertension, antihyper-tensive treatment and sudden coronary death: The Framingham Study, Hyper-tension. 1988;11:II45-II50.
50. Arnesen E, Thelle DS, Førde OH, Mjøs OD. Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977. J Epidemiol Community Health. 1983;37:141-144.
51. Grines CL, Topol EJ, O'Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 1995;91:298-303.
52. Bulpitt CJ, Beilin LJ, Clifton P, et al. Risk factors for death in treated hypertensive patients: report from the D.H.S.S. Hypertension Care Computing Project. Lancet. 1979;2:134-137.
53. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988; 2:349-360.